Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Align Technology, Inc. (ALGN:NASDAQ), powered by AI.
Align Technology, Inc. is currently trading at $174.84. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Align Technology, Inc. on Alpha Lenz.
Align Technology, Inc.'s P/E ratio is 30.9.
“Align Technology, Inc. trades at a P/E of 30.9 (premium valuation) with solid ROE of 10.4%.”
Ask for details →Align Technology, Inc. is a publicly traded company specializing in the development, manufacture, and marketing of innovative medical devices, primarily within the dental and orthodontic sectors. The company's flagship product line centers on clear aligner systems designed to offer orthodontic treatment alternatives to traditional metal braces, serving patients seeking aesthetically appealing and less invasive dental correction. Align Technology also delivers digital scanning and imaging solutions that support clinical workflows in dentistry, enhancing treatment planning and patient outcomes. Operating on a global scale, Align Technology plays a significant role in advancing digital dentistry and orthodontics through technological innovation, intellectual property, and ongoing research and development. The company’s products are adopted by dental professionals and clinics worldwide, supporting a shift in how orthodontic care is delivered. As a component of the medical equipment and supplies industry, Align Technology is positioned among notable mid-to-large capitalization companies and demonstrates strong free-float ownership, reflecting broad institutional and public investor interest. Its activities and technologies have considerable influence on the healthcare ecosystem, particularly in improving access to advanced dental care and streamlining clinical practices.
“Align Technology, Inc. trades at a P/E of 30.9 (premium valuation) with solid ROE of 10.4%.”
Ask for details →Align Technology, Inc. (ticker: ALGN) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 21,485 employees. Market cap is $12.7B.
The current price is $174.84 with a P/E ratio of 30.91x and P/B of 3.13x.
ROE is 10.39% and operating margin is 14.51%. Annual revenue is $4.0B.